Loading... 2 0 5 0 false
Credit Name
Anthony P Schwarer
Full Name
Schwarer, Anthony P
 
 
Loading... 3 0 5 0 false

Publications

Results 1-9 of 9 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
126-Apr-2021The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.Rees, Matthew J ; Wu, Simon; Mokoonlall, Mridula; Dix, Caroline H K; Bryant, Christian E; D'Rozario, James; Schwarer, Anthony P ; Grigg, Andrew P ; Tiong, Ing S 
226-May-2020Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia.Tiong, Ing S ; Dillon, Richard; Ivey, Adam; Teh, Tse-Chieh; Nguyen, Phillip; Cummings, Nicholas; Taussig, David C; Latif, Annie-Louise; Potter, Nicola E; Runglall, Manohursingh; Russell, Nigel H; Raj, Kavita; Schwarer, Anthony P ; Fong, Chun Yew ; Grigg, Andrew P ; Wei, Andrew H
3Jul-2019Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response.Hamadi, Abdullah; Grigg, Andrew P ; Dobie, Gasim; Burbury, Kate L; Schwarer, Anthony P ; Kwa, Faith A; Jackson, Denise E
4Dec-2018A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML.Schwarer, Anthony P ; Butler, Jason; Jackson, Kathryn; Beligaswatte, Ashanka; Martin, Louisa; Kennedy, Glen; Daniela, Zantomio; Lewis, Ian; Hiwase, Devendra; Wight, Joel C ; He, Simon ; Grigg, Andrew; Morris, Kirk; Mollee, Peter; Marlton, Paula
52018Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.Ross, David M; Pagani, Ilaria S; Shanmuganathan, Naranie; Kok, Chung H; Seymour, John F; Mills, Anthony K; Filshie, Robin J; Arthur, Christopher K; Dang, Phuong; Saunders, Verity A; Braley, Jodi; Yong, Agnes S; Yeung, David T; White, Deborah L; Grigg, Andrew P ; Schwarer, Anthony P ; Branford, Susan; Hughes, Timothy P
6Jun-2017Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab eraTamjid, Babak ; Mckendrick, Joseph; Schwarer, Anthony P ; Doig, Rowan; James, Philip; Hosking, Patrick; Hawkes, Eliza A 
723-May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.Fox, Lucy C; Cummins, Katherine D; Costello, Ben; Yeung, David; Cleary, Rebecca; Forsyth, Cecily; Tatarczuch, Maciek; Burbury, Kate; Motorna, Olga; Shortt, Jake; Fleming, Shaun; McQuillan, Andrew; Schwarer, Anthony P ; Harrup, Rosemary; Holmes, Amy; Ratnasingam, Sumita; Chan, Kah-Lok; Hsu, Wei-Hsun; Ashraf, Asma; Putt, Faye; Grigg, Andrew P
8Apr-2016Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern eraJalali, Azim; Ha, Francis J; Chong, Geoff; Grigg, Andrew P ; Mckendrick, Joe; Schwarer, Anthony P ; Doig, Rowan; Hamid, Anis; Hawkes, Eliza A 
917-Dec-2014TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.Yeung, David T; Osborn, Michael P; White, Deborah L; Branford, Susan; Braley, Jodi A; Herschtal, Alan; Kornhauser, Michael; Issa, Samar; Hiwase, Devendra K; Hertzberg, Mark; Schwarer, Anthony P ; Filshie, Robin; Arthur, Christopher K; Kwan, Yiu Lam; Trotman, Judith; Forsyth, Cecily J; Taper, John; Ross, David M; Beresford, Jennifer; Tam, Constantine; Mills, Anthony K; Grigg, Andrew P ; Hughes, Timothy P